Endava Announces First Quarter Fiscal Year 2025 Results
Endava plc (NYSE:
DAVA) ("Endava" or the "Company"), a leading technology services company combining world-class engineering, industry expertise and a people-centric mindset, today announced results for the three months ended September 30, 2024, the first quarter of its 2025 fiscal year ("Q1 FY2025").
Endava to Announce Q1 FY2025 Financial Results on November 12, 2024
Endava plc (NYSE:
DAVA), a leading next-generation technology services provider, today announced it will release results for the first quarter ended September 30, 2024, on Tuesday November 12, 2024 before the opening of regular U.S. market hours.
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Endava, plc (DAVA)
The Law Offices of Frank R. Cruz reminds investors of the upcoming October 25, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Endava, plc (“Endava” or the “Company”) (NYSE:
DAVA) securities between May 23, 2023 and February 28, 2024, inclusive (the “Class Period”).
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Methode Electronics, Starbucks, Endava, and Sage and Encourages Investors to Contact the FirmNEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Methode Electronics Inc. (NYSE:
MEI), Starbucks Corporation (NASDAQ:
SBUX), Endava PLC (NYSE:
DAVA), and Sage Therapeutics, Inc. (NASDAQ:
SAGE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
DAVA Deadline: RLF Urges Endava plc (NYSE: DAVA) Stockholders to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of Endava plc (NYSE:
DAVA) between May 23, 2023 and February 28, 2024. Endava describes itself as a company that “provides technology services for clients in consumer products, healthcare, mobility, and retail verticals in North America and internationally.”
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of EndavaFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Endava To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Outset Medical, Starbucks, Endava, and Sage and Encourages Investors to Contact the FirmNEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Outset Medical, Inc. (NASDAQ:
OM), Starbucks Corporation (NASDAQ:
SBUX), Endava PLC (NYSE:
DAVA), and Sage Therapeutics, Inc. (NASDAQ:
SAGE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of EndavaFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Endava To Contact Him Directly To Discuss Their Options
Endava to Host Investor Day on November 13, 2024
Endava plc (NYSE:
DAVA), a leading provider of next-generation technology services, today announced its upcoming investor day, taking place on Wednesday, November 13, 2024.
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Outset Medical, Starbucks, Endava, and Sage and Encourages Investors to Contact the FirmNEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Outset Medical, Inc. (NASDAQ:
OM), Starbucks Corporation (NASDAQ:
SBUX), Endava PLC (NYSE:
DAVA), and Sage Therapeutics, Inc. (NASDAQ:
SAGE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Outset Medical, Starbucks, Endava, and Sage and Encourages Investors to Contact the FirmNEW YORK, Oct. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Outset Medical, Inc. (NASDAQ:
OM), Starbucks Corporation (NASDAQ:
SBUX), Endava PLC (NYSE:
DAVA), and Sage Therapeutics, Inc. (NASDAQ:
SAGE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
DAVA REMINDER – Robbins LLP Reminds DAVA Stockholders to Seek Counsel in Light of the Pending Lead Plaintiff DeadlineSAN DIEGO, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Endava PLC (NYSE:
DAVA) securities between May 23, 2023 and February 28, 2024. Endava provides technology services for clients in consumer products, healthcare, mobility, and retail verticals in North America.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of EndavaFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Endava To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Outset Medical, Starbucks, Endava, and Sage and Encourages Investors to Contact the FirmNEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Outset Medical, Inc. (NASDAQ:
OM), Starbucks Corporation (NASDAQ:
SBUX), Endava PLC (NYSE:
DAVA), and Sage Therapeutics, Inc. (NASDAQ:
SAGE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
